Explore our news

01.07.2020

New name – proven strengths

STADA GmbH becomes STADA Consumer Health Deutschland GmbH

17.06.2020

STADA Health Report 2020

Europe demands compulsory vaccinations

08.06.2020

Nidda Healthcare GmbH intends to conduct a squeeze-out

Squeeze-out of minority shareholders in STADA Arzneimittel AG under stock corporation law

06.05.2020

Bausch + Lomb licenses exclusive rights from STADA and Xbrane

To a biosimilar candidate for Lucentis (ranibizumab) in the United States and Canada

21.04.2020

Thank you healthcare professionals

You never give up and stay strong together against COVID-19 and other diseases.

20.04.2020

Corona Survey

Insights into how people in four major European countries are feeling about healthcare issues amid the COVID-19 crises.

17.04.2020

STADA supports authorities with tailored donations and services

Numerous initiatives are underway in the battle against COVID-19.

09.04.2020

Thank you pharmacy

With good advice and tireless commitment, you stand by your patients day after day, especially in these challenging COVID-19 times.

Grippostad® C

Stark bei Erkältung.

Hoggar® Night TV Spot

Einfach gut schlafen.

Hedrin®

und aus die Laus!

Nizoral®

Zur Behandlung von Kopfschuppen.

Nizoral®

Zur Behandlung von Kopfschuppen.

STADA on YouTube

Get in touch

For Journalists

STADA Arzrneimittel AG
Media Relations
61118 Bad Vilbel

Phone: +49(0) 6101 603-165

Fax: +49(0) 6101 603-215

press@stada.de

For Customers, Business Partners & general inquiries

STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel

Phone: +49(0) 6101 603-0

Fax: +49(0) 6101 603-215

info@stada.de